LMR Master Fund’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
$1.78M Buy
33,578
+29,120
+653% +$1.48M 0.18% 170
2013
Q3
$207K Sell
4,458
-47,034
-91% -$2.06M 0.04% 271
2013
Q2
$2.3M Buy
+51,492
New +$2.24M 0.21% 145

Other funds holding BMY

LMR Master Fund's BMY Position: Q4 2013 in Review

LMR Master Fund increased its Bristol-Myers Squibb (BMY) stake by 653% in Q4 2013, buying an estimated $1.48M and bringing the position to 33,578 shares worth $1.78M. The position accounts for 0.18% of the portfolio, ranked #170.

LMR Master Fund first reported a position in BMY in Q2 2013 and has held it in 3 quarters since. The position peaked at $2.3M in Q2 2013. 1,314 funds tracked by Wall St. Rank hold BMY as of Q4 2013.

  • LMR Master Fund held 33,578 shares of Bristol-Myers Squibb worth $1.78M as of Q4 2013.
  • LMR Master Fund bought 29,120 Bristol-Myers Squibb shares in Q4 2013, an estimated $1.48M.
  • Bristol-Myers Squibb made up 0.18% of LMR Master Fund's portfolio in Q4 2013, its #170 holding.
  • LMR Master Fund first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 3 quarters since.
  • LMR Master Fund's Bristol-Myers Squibb position peaked at $2.3M in Q2 2013.
  • 1,314 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.